Collection
Tumor Cell Intrinsic Mechanisms of Immune Escape
- Submission status
- Closed
Editors
-
Ganapathy Sriram
Ganapathy Sriram, PhD., is currently a Senior Scientist at EMD Serono Research and Development Institute Inc. (Cambridge, MA). He obtained his PhD from Rutgers, The State University of New Jersey studying tyrosine phosphorylation and oncogene signaling in cancer biology and did his post-doc at the Massachusetts Institute of Technology. Dr. Sriram’s research focuses on how DNA damage and tumor cell injury can activate dendritic cell function and promote anti-tumor immunity.
-
Raymond Birge
Raymond Birge, PhD., is a Professor at Rutgers, The State University of New Jersey and member of the New Jersey Medical School Cancer Center. Dr. Birge joined UMDNJ-New Jersey Medical School in 2000 and currently holds a position of Professor and Vice Chair for Research in the Department of Microbiology, Biochemistry and Molecular Biology. Dr. Birge also has joint appointments at the New Jersey Medical School Cancer Center (Newark) and the Cancer Institute of New Jersey (New Brunswick).
Articles (22 in this collection)
-
-
Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages
Authors (first, second and last of 13)
- Stoyan Tankov
- Marija Petrovic
- Paul R. Walker
- Content type: Research
- Open Access
- Published: 22 February 2024
- Article: 144
-
Tumorous IRE1α facilitates CD8+T cells-dependent anti-tumor immunity and improves immunotherapy efficacy in melanoma
Authors (first, second and last of 15)
- Yuqi Yang
- Sijia Wang
- Weinan Guo
- Content type: Research
- Open Access
- Published: 30 January 2024
- Article: 83
-
Macrophage barrier in the tumor microenvironment and potential clinical applications
Authors
- Shuai Ji
- Yuqing Shi
- Bo Yin
- Content type: Review
- Open Access
- Published: 26 January 2024
- Article: 74
-
The role of exhausted natural killer cells in the immunopathogenesis and treatment of leukemia
Authors (first, second and last of 7)
- Asal Barshidi
- Keivan Ardeshiri
- Farhad Jadidi-Niaragh
- Content type: Review
- Open Access
- Published: 22 January 2024
- Article: 59
-
Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression
Authors (first, second and last of 7)
- Shujun Zhang
- Yafeng Liu
- Xinyu Gu
- Content type: Review
- Open Access
- Published: 17 January 2024
- Article: 49
-
Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate
Authors (first, second and last of 15)
- Elizabeth Cooper
- Caitlin R. M. Oyagawa
- Thomas I-H. Park
- Content type: Research
- Open Access
- Published: 11 January 2024
- Article: 30
-
Tumor immune escape: extracellular vesicles roles and therapeutics application
Authors
- Mahdi Ahmadi
- Reza Abbasi
- Jafar Rezaie
- Content type: Review
- Open Access
- Published: 02 January 2024
- Article: 9
-
IL-1β mediates the induction of immune checkpoint regulators IDO1 and PD-L1 in lung adenocarcinoma cells
Authors (first, second and last of 7)
- Afshan Fathima Nawas
- Ashley Solmonson
- Carole R. Mendelson
- Content type: Research
- Open Access
- Published: 20 November 2023
- Article: 331
-
Targeting CD24 as a novel immunotherapy for solid cancers
Authors (first, second and last of 4)
- Yan Yang
- Guangming Zhu
- Yun Yang
- Content type: Review
- Open Access
- Published: 02 November 2023
- Article: 312
-
LFA-1 knockout inhibited the tumor growth and is correlated with treg cells
Authors (first, second and last of 10)
- Ting Niu
- Zhengyang Li
- Jiangchao Li
- Content type: Research
- Open Access
- Published: 18 September 2023
- Article: 233
-
The emerging roles of MAPK-AMPK in ferroptosis regulatory network
Authors (first, second and last of 5)
- Xinyue Wang
- Xiao Tan
- Hongjuan Shi
- Content type: Review
- Open Access
- Published: 14 August 2023
- Article: 200
-
Non-POU Domain-Containing Octomer-Binding (NONO) protein expression and stability promotes the tumorigenicity and activation of Akt/MAPK/β-catenin pathways in human breast cancer cells
Authors (first, second and last of 9)
- Bilal Ahmad Lone
- Fouzia Siraj
- Yuba Raj Pokharel
- Content type: Research
- Open Access
- Published: 27 June 2023
- Article: 157
-
The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape
Authors (first, second and last of 10)
- Diandra Zipinotti dos Santos
- Josiany Carlos de Souza
- Leticia B. A. Rangel
- Content type: Review
- Open Access
- Published: 27 June 2023
- Article: 161
-
KRAS, MYC, and ARF6: inseparable relationships cooperatively promote cancer malignancy and immune evasion
Authors
- Hisataka Sabe
- Content type: Review
- Open Access
- Published: 08 May 2023
- Article: 106
-
KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
Authors (first, second and last of 7)
- Reem Alkhayer
- Viviane Ponath
- Elke Pogge von Strandmann
- Content type: Research
- Open Access
- Published: 04 May 2023
- Article: 94
-
Intrinsic signalling factors associated with cancer cell-cell fusion
Authors
- Thomas Dittmar
- Ralf Hass
- Content type: Review
- Open Access
- Published: 04 April 2023
- Article: 68
-
Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells
Authors (first, second and last of 6)
- Anudari Letian
- Eyoel Yemanaberhan Lemma
- Timothy E. McGraw
- Content type: Research
- Open Access
- Published: 13 March 2023
- Article: 58
-
Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions
Authors
- Alex Watterson
- Matthew A. Coelho
- Content type: Review
- Open Access
- Published: 02 March 2023
- Article: 45
-
c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment
Authors (first, second and last of 5)
- Fang-yan Gao
- Xin-tong Li
- Xiao-xiang Guan
- Content type: Review
- Open Access
- Published: 31 January 2023
- Article: 28
-
Elevation of spermine remodels immunosuppressive microenvironment through driving the modification of PD-L1 in hepatocellular carcinoma
Authors (first, second and last of 12)
- Hong-Xiang Shi
- Chao Liang
- Dong Fang
- Content type: Research
- Open Access
- Published: 08 November 2022
- Article: 175
-
ARID1A deficiency reverses the response to anti-PD(L)1 therapy in EGFR-mutant lung adenocarcinoma by enhancing autophagy-inhibited type I interferon production
Authors (first, second and last of 7)
- Dantong Sun
- Haili Qian
- Puyuan Xing
- Content type: Research
- Open Access
- Published: 13 October 2022
- Article: 156